Brief: Medivir Enters Into Licensing Agreement With Ubiquigent For Preclinical Program USP7

Medivir AB

10/02/2021 14:08

Feb 10 (Reuters) - Medivir AB  MVIRb.ST :
    * MEDIVIR ENTERS INTO LICENSING AGREEMENT WITH UBIQUIGENT
FOR
PRECLINICAL PROGRAM USP7
    * MEDIVIR HAS GRANTED UBIQUIGENT AN EXCLUSIVE WORLDWIDE
LICENSE TO
DEVELOP AND COMMERCIALIZE PROGRAM INCLUDING ALL ASSOCIATED
COMPOUNDS ACROSS ANY THERAPEUTIC INDICATION(S)

Source text for Eikon:  ID:nWkr8jBXGk 
Further company coverage:  MVIRb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))